Your session is about to expire
← Back to Search
Behavioural Intervention
Sleep and Circadian Rhythm Study for High Blood Pressure (SCN-BP Trial)
N/A
Waitlist Available
Led By Stephen J Thomas, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant in the parent grant (IDH-MEGA)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurements obtained every 30 minutes over 30 hours
Awards & highlights
SCN-BP Trial Summary
This trial looks at how sleep and body clock affect nighttime blood pressure.
Who is the study for?
This trial is for participants of the parent grant IDH-MEGA who are interested in understanding how sleep and their body's internal clock affect nighttime blood pressure.Check my eligibility
What is being tested?
The study is exploring how sleep patterns and circadian rhythms influence high blood pressure at night using a Constant Routine Protocol to monitor changes.See study design
What are the potential side effects?
Since this trial involves monitoring rather than medication, side effects are minimal but may include discomfort from wearing monitoring equipment or disruption of normal sleep patterns.
SCN-BP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSCN-BP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measurements obtained every 30 minutes over 30 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurements obtained every 30 minutes over 30 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Core body temperature
Change in Melatonin
Secondary outcome measures
Change in Blood pressure
SCN-BP Trial Design
1Treatment groups
Experimental Treatment
Group I: Constant Routine ProtocolExperimental Treatment1 Intervention
Participants complete a 30-hour constant routine protocol to directly examine markers of endogenous circadian rhythms. In a constant routine protocol, participants remain in a dimly lit room (<10 lux), in a semi-recumbent posture, remain awake, and consume iso-caloric snacks. Saliva samples are collected and core body temperature and blood pressure are measured.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,581 Previous Clinical Trials
2,277,959 Total Patients Enrolled
1 Trials studying Sleep
87 Patients Enrolled for Sleep
Stephen J Thomas, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are already taking part in the main study called IDH-MEGA.
Research Study Groups:
This trial has the following groups:- Group 1: Constant Routine Protocol
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this research study currently open?
"As per the details on clinicaltrials.gov, this particular medical experiment is not presently acquiring applicants. It was initially announced on June 1st 2023 and edited most recently on June 22nd 2023. Despite that no individuals are being sought for this trial at present time, there are 952 other studies seeking participants right now."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger